Abortifacient Agents, Nonsteroidal
"Abortifacient Agents, Nonsteroidal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Non-steroidal chemical compounds with abortifacient activity.
| Descriptor ID |
D000020
|
| MeSH Number(s) |
D27.505.696.875.131.100 D27.505.954.705.131.100
|
| Concept/Terms |
Abortifacient Agents, Nonsteroidal- Abortifacient Agents, Nonsteroidal
- Agents, Nonsteroidal Abortifacient
- Nonsteroidal Abortifacient Agents
- Abortifacient Agents, Non-Steroidal
- Abortifacient Agents, Non Steroidal
- Agents, Non-Steroidal Abortifacient
- Non-Steroidal Abortifacient Agents
|
Below are MeSH descriptors whose meaning is more general than "Abortifacient Agents, Nonsteroidal".
Below are MeSH descriptors whose meaning is more specific than "Abortifacient Agents, Nonsteroidal".
This graph shows the total number of publications written about "Abortifacient Agents, Nonsteroidal" by people in this website by year, and whether "Abortifacient Agents, Nonsteroidal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 1 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 5 | 0 | 5 |
| 2023 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Abortifacient Agents, Nonsteroidal" by people in Profiles.
-
Bleck RR, Danvers AA, Nimbvikar A, Gurney EP. Medical management of early pregnancy loss with mifepristone and misoprostol in emergency departments compared to a Complex Family Planning office: Implementation of a COVID-19 institutional policy change. Contraception. 2024 08; 136:110467.
-
Sanchez-Ramos L, Levine LD, Sciscione AC, Mozurkewich EL, Ramsey PS, Adair CD, Kaunitz AM, McKinney JA. Methods for the induction of labor: efficacy and safety. Am J Obstet Gynecol. 2024 03; 230(3S):S669-S695.
-
Al-Hafez L, Bicocca MJ, Chauhan SP, Berghella V. Prostaglandins for induction in pregnancies with fetal growth restriction. Am J Obstet Gynecol MFM. 2022 03; 4(2):100538.
-
Vinekar K, Achilles SL, Chen BA. Management of heterotopic pregnancy with uterine aspiration and systemic two-dose methotrexate. Contraception. 2021 10; 104(4):444-446.
-
Tam Tam H, Putterman D, Sinha R, Woods Ludwig J, Gulersen M. Computed tomography-guided injection for management of caesarean scar pregnancy. Clin Radiol. 2021 Sep; 76(9):696-700.
-
Achenbach AE, Singh S, Jackson B, Caveglia SJ, Berghella V, Seligman NS. Cervical ripening with laminaria tents prior to second trimester induction of labor. J Matern Fetal Neonatal Med. 2022 Dec; 35(25):5807-5812.
-
Cohen M, Edelman A, Bellussi F, Berghella V, Haas DM. Cochrane Review Summaries-April 2021. Obstet Gynecol. 2021 Apr 01; 137(4):747-749.
-
Berghella V, Bellussi F. Misoprostol before surgical abortion: evidence-based and ready to be incorporated in clinical guidelines to change practice. Am J Obstet Gynecol MFM. 2020 11; 2(4):100254.
-
Perriera L, Creinin MD. Misoprostol before to first-trimester surgical abortion: do not jump on the bandwagon, not all evidence is created equal. Am J Obstet Gynecol MFM. 2020 11; 2(4):100244.
-
Morra I, Ferrara C, Sglavo G, Sansone A, Saccone G, Perriera L, Di Carlo C. Incidence of uterine rupture in second-trimester abortion with gemeprost alone compared to mifepristone and gemeprost. Contraception. 2019 03; 99(3):152-154.